Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients.
Assessment of Seroconversion to SARS-CoV-2 in a Cohort of Pediatric Kidney Transplant Recipients.
复制标题
DOI:
10.3389/fped.2020.601327
复制
发表时间:
2020
影响因子:
2.6
通讯作者:
Hains DS
中科院分区:
文献类型:
--
作者:
Nailescu C;Khalid M;Wilson AC;Amanat F;Arregui S;Canas J;Hooks J;Krammer F;Schwaderer AL;Hains DS
Background: The occurrence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the associated coronavirus disease 2019 (COVID-19) have profoundly affected adult kidney disease patients. In contrast, pediatric solid organ transplant recipients, including pediatric kidney transplant (KT) recipients, do not seem to be at particularly higher risk for SARS-CoV-2 infection or for severe COVID-19 disease. This patient population might be protected by certain mechanisms, such as the immunosuppressive medications with their anti-inflammatory properties or simply being well-versed in self-protection techniques. Assessing SARS-CoV-2 antibody serologies could potentially help understand why this patient population is apparently spared from severe SARS-CoV-2 clinical courses. Objective: To examine SARS-CoV-2 serologic status in a cohort of pediatric KT recipients. Methods: SARS-CoV-2 anti-spike IgG and IgM antibodies were measured by three different methods in pediatric KT recipients coming for routine clinic visits immediately post-confinement in May-June of 2020. The patients were considered seroconverted if SARS-CoV-2 antibodies were positive by 2/3 methods and weak positive/indeterminate if positive by 1/3. Results: Thirty-one patients were evaluated (about 1/3 of our institution's pediatric KT population). One patient seroconverted, while three were considered weak positive/indeterminate. None were symptomatic and none had nasopharyngeal PCR confirmed SARS-CoV-2 disease. Conclusions: Seroconversion to SARS-CoV-2 was rare in this population and likely reflects the social distancing practiced by these patients. The results will serve as a foundation for a future longitudinal study to evaluate the long-term emergence and persistence of antibodies in this population and may inform studies of response to a future vaccine.
登录
查看更多内容
DOI:
10.1093/jpids/piaa095
发表时间:
2020-11-01
影响因子:
3.2
作者:
Downes, Kevin J.;Danziger-Isakov, Lara A.;Ardura, Monica, I
通讯作者:
Ardura, Monica, I
影响因子:
82.9
作者:
Amanat F;Stadlbauer D;Strohmeier S;Nguyen THO;Chromikova V;McMahon M;Jiang K;Arunkumar GA;Jurczyszak D;Polanco J;Bermudez-Gonzalez M;Kleiner G;Aydillo T;Miorin L;Fierer DS;Lugo LA;Kojic EM;Stoever J;Liu STH;Cunningham-Rundles C;Felgner PL;Moran T;García-Sastre A;Caplivski D;Cheng AC;Kedzierska K;Vapalahti O;Hepojoki JM;Simon V;Krammer F
通讯作者:
Krammer F
影响因子:
8.8
作者:
Fung, Monica;Chiu, Charles Y.;Babik, Jennifer M.
通讯作者:
Babik, Jennifer M.
影响因子:
--
作者:
Stadlbauer, Daniel;Amanat, Fatima;Krammer, Florian
通讯作者:
Krammer, Florian
DOI:
10.1098/rspb.2014.3085
发表时间:
2015-12-22
期刊:
Proceedings. Biological sciences
影响因子:
--
作者:
Simon AK;Hollander GA;McMichael A
通讯作者:
McMichael A